Ubhi, Tajinder http://orcid.org/0000-0002-9107-1888
Zaslaver, Olga
Quaile, Andrew T. http://orcid.org/0000-0002-1194-3712
Plenker, Dennis http://orcid.org/0000-0003-3895-4064
Cao, Pinjiang
Pham, Nhu-An
Békési, Angéla
Jang, Gun-Ho
O’Kane, Grainne M. http://orcid.org/0000-0002-8690-403X
Notta, Faiyaz
Moffat, Jason
Wilson, Julie M. http://orcid.org/0000-0003-2510-962X
Gallinger, Steven http://orcid.org/0000-0002-6998-9414
Vértessy, Beáta G.
Tuveson, David A.
Röst, Hannes L.
Brown, Grant W. http://orcid.org/0000-0002-9002-5003
Funding for this research was provided by:
Gouvernement du Canada | Canadian Institutes of Health Research (FDN-159913, PJT-463531, FRN 166094)
Canada Research Chairs
Canadian Cancer Society Research Institute (Innovate grant 706293)
Ontario Institute for Cancer Research (P.CTIP.1005)
Ontario Ministry of Colleges and Universities
GlaxoSmithKline Chair in Genetics and Genome Biology at the Hospital for Sick Children
Princess Margaret Cancer Foundation
Terry Fox Research Institute
Canadian Friends of the Hebrew University
Lustgarten Foundation
U.S. Department of Health & Human Services | National Institutes of Health (5P30CA45508, U01CA210240, R01CA229699, U01CA224013, 1R01CA188134, and 1R01CA190092)
Simons Foundation (552716)
Cold Spring Harbor Laboratory Association Cold Spring Harbor Laboratory and Northwell Health Affiliation Northwell Health Tissue Donation Program
Canada Foundation for Innovation (grant 37660)
Hungarian Academy of Sciences | Magyar Tudományos Akadémia Számítástechnikai és Automatizálási Kutatóintézet
National Research, Development and Innovation Fund of Hungary
Article History
Received: 20 October 2022
Accepted: 9 February 2024
First Online: 6 March 2024
Competing interests
: D.A.T. receives stock options from Leap Therapeutics, Surface Oncology, Sonata Therapeutics and Mestag Therapeutics outside of the published work. D.A.T. is scientific cofounder of Mestag Therapeutics. D.A.T. has received research grant support from the Fibrogen, Mestag and ONO Therapeutics. D.A.T. receives grant funding from the Lustgarten Foundation, the National Institutes of Health and the Thompson Foundation. None of this work is related to the publication. T.U. and G.W.B. were consultants for Repare Therapeutics. G.W.B. received research support from Repare Therapeutics. The other authors report no competing interests.